EVENT

5th Annual Outsourcing in Clinical Trials Medical Devices Europe
Munich, Germany
​​​​​​​7th – 8th February 2018

Event Background:

Outsourcing in Clinical Trials: Medical Devices Europe has now reached it’s fifth birthday. This event is focused on Medical devices. At this event you will learn about the new regulations, which were released this may, regarding medical devices in more detail, from speakers who are the heads in their respective fields.

Also, you will learn about the EUDAMED, pharma database system and GDPR here at OCT Medical Devices this year. Doing so will benefit you extremely!

Attending this event will boost your understanding with the new regulations, which will be implemented in 2020, and how to effectively use the EUDAMED and GDPR.


Why now:

There are changes happening right now across Europe for medical device regulations – regulatory authorities are asking for a lot more and a great variety of products. Also, there is a perception that the US regulatory process has become more difficult, and companies are acting by choosing to launch within Europe as it is perceived as a more predictable regulatory environment where they can work with CROs for a more local expert.

More than half of medical device companies are expected to hire additional employees to handle new business in the next year- teams are expanding indicating there is a huge delegate space to invite. Also, the lack of regulatory resources within organisations has prompted the move for smaller medical device companies to work in collaboration with CROs.

Lastly, the global market for medical device outsourcing is predicated for growth over the next few years as brand owners increasingly transfer in-house manufacturing processes to third-party companies to streamline production costs and improve access to emerging markets. Service providers are meeting this demand by changing their models from functional to full service models instead.

There are changes happening right now across Europe for medical device regulations – regulatory authorities are asking for a lot more and a great variety of products